Chinese Med J Peking
-
Chinese Med J Peking · Dec 2010
ReviewAnalysis of isocitrate dehydrogenase-1/2 gene mutations in gliomas.
To highlight recent researches which may show promise for histomolecular classification and new treatments for gliomas. ⋯ Isocitrate dehydrogenase-1/2 mutations define a specific subtype of gliomas and may have great significance in the diagnosis, prognosis, and treatment of patients with these tumors.